View the docket here: www.regulations.gov/document/CDC... See the CDC’s ACIP meeting page for additional meeting details: www.cdc.gov/acip/meeting...

Regulations.gov

Below are some key talking points for your comment, and a sample comment with references is below the divider. Please feel free to copy, modify, and share any of the text for your own advocacy.

We need universal access to the updated COVID vaccines for people of all ages, and regardless of medical conditions, at least once a year. COVID vaccines reduce the risk of Long COVID and severe disease for people of all ages.

Vaccine recommendation frameworks must include strong ethical foundations and must make advances in disease prevention available to all. l

fda.gov/media/186593/d...

You should also include brief comments about why vaccination matters to you personally, such as how vaccination for COVID and a broad range of infectious diseases has positively impacted you and your community.

Optionally, at the beginning of your comment, you may also include whether or not you have any financial conflicts of interest relevant to the topic.

Don’t worry about making your comment perfect or polished–your perspective matters, and this committee needs to hear how their attacks on vaccine access are impacting all of us.

fda.gov/media/186593/d...

Submit Your Comment Sample Comment and References Docket: CDC-2026-0199 March 2, 2026 Public Comment for the March 18, 2026, CDC ACIP Committee Meeting

To the CDC Advisory Committee on Immunization Practices: I have no conflicts of interest to disclose. You must reinstate unhindered universal COVID vaccine recommendations for people of all ages, at least once a year, for all COVID vaccine formulations.

fda.gov/media/186593/d...

COVID vaccination reduces the risk of Long COVID, severe acute disease, disability, and death for people of all ages [1-9]. Vaccination within the last year with formulations updated to match the latest circulating COVID strains is needed for the best protection.

Vaccine recommendation frameworks must include strong ethical foundations and make advances in disease prevention available to all. Denying access to safe and effective vaccines and treatments under the guise of research is a practice that has been recognized as unethical and unacceptable.

Thankfully, officials in Guinea-Bissau have stopped a harmful CDC-funded trial that would have denied access to the birth dose of the hepatitis B vaccine for thousands of babies [10].

This committee must recommend all safe and effective vaccines to ensure broad access at pharmacies, insurance coverage, and coverage for uninsured children through the Vaccines for Children program.

Hepatitis B, HPV, MMR, MMRV, RSV, and other vaccines prevent unnecessary infections, harmful consequences of infections, and deaths of children and adults. Vaccine access should not depend on what state you live in, and no one should die because of a lack of access to affordable vaccines.

fda.gov/media/186593/d...

References Link-Gelles R, Chickery S, Webber A, et al. Interim Estimates of 2024–2025 COVID-19 Vaccine Effectiveness Among Adults Aged ≥18 Years — VISION and IVY Networks, September 2024–January 2025. MMWR Morb Mortal Wkly Rep. 2025;74. doi:10.15585/mmwr.mm7406a1

Appaneal HJ, Lopes VV, Nguyen JL, Volkman HR, Zasowski EJ, Caffrey AR. Early effectiveness of the BNT162b2 LP.8.1 vaccine against COVID-19 emergency department, urgent care, and outpatient visits in the US Veterans Affairs Healthcare System. medRxiv.

Preprint posted online January 23, 2026:2026.01.22.26344618. doi:10.64898/2026.01.22.26344618 Fang Z, Ahrnsbrak R, Rekito A. Evidence Mounts That About 7% of US Adults Have Had Long COVID. JAMA. Published online June 7, 2024. doi:10.1001/jama.2024.11370

Liu C, Liu C, Yan R, et al. Association of COVID vaccinations and treatments with long COVID beyond 6 months: a case-control study on the adult population in a large integrated healthcare system in the United States from 2020 to 2023.